Canton Strategic Holdings, Inc.

Canton Strategic Holdings, Inc. (formerly Tharimmune, Inc.) has undergone a significant strategic shift in late 2025, transitioning from primarily a clinical-stage biotechnology company to one prioritizing digital asset treasury management and investment in the Canton Network ¹. The company's core business model now revolves around acquiring, holding, and deploying Canton Coin ("CC") and supporting the Canton Network through various activities. This includes operating as a Super Validator and running additional validator nodes to earn recurring protocol-based validation rewards in CC, building or investing in applications and middleware that complement capital markets transactions on the Canton Network, and collaborating with other ecosystem participants to enhance network utilization ². The company also plans capital raising and treasury expansion, potentially deploying proceeds towards additional CC acquisitions and Canton-related ecosystem investments, and engaging in token management strategies like locking, lending, and options to generate yield and manage risk ². Canton Strategic is an active participant in the Canton Foundation, helping to shape the network's governance framework, tokenomics, and strategic roadmap ².

The company's operations are divided into two reportable segments: digital assets and clinical-stage biotechnology ³. The digital assets segment focuses on the CC-centric digital asset treasury strategy, while the clinical-stage biotechnology segment, operated through its wholly-owned subsidiary Gravitas, develops therapeutic candidates for immunology and inflammation conditions ³.

For the fiscal year ended December 31, 2025, Canton Strategic reported a net loss of $35.916 million ⁴, an increase from a net loss of $12.197 million ⁵ in the prior year. Total operating expenses increased to $20.106 million ⁶ in 2025 from $12.433 million ⁷ in 2024. The company recognized an unrealized loss from digital asset holdings of $22.010 million ⁸ in 2025, compared to $0 ⁹ in 2024, reflecting the initiation of its digital asset strategy. Cash and cash equivalents stood at $17.032 million ¹⁰ as of December 31, 2025, up from $3.559 million ¹¹ at December 31, 2024. Total assets were $519.146 million ¹² in 2025, a substantial increase from $3.721 million ¹³ in 2024, primarily due to the acquisition of digital assets valued at $501.760 million ¹⁴. Total liabilities were $121.220 million ¹⁵ in 2025, compared to $2.413 million ¹⁶ in 2024, including a deferred tax liability of $117.934 million ¹⁷ related to the Cryptocurrency Offering. The company had an accumulated deficit of $72.817 million ¹⁸ as of December 31, 2025.

Year-over-year, research and development expenses decreased by $3.3 million ¹⁹, or 52% ²⁰, from $6.392 million ²¹ in 2024 to $3.073 million ²² in 2025. This decrease was primarily due to a $1.6 million ²³ reduction in clinical trial expenses for GV104, a $1.5 million ²⁴ decrease in license fees, and a $0.9 million ²⁵ decrease in pre-clinical expenses, partially offset by increases in CMC expenses and stock-based compensation ²². General and administrative expenses, however, increased by $11.0 million ²⁶, or 182% ²⁷, to $17.032 million ²⁸ in 2025 from $6.041 million ²⁹ in 2024, driven by increases in personnel expenses, investor relations, and stock-based compensation related to general and administrative staff ²⁸. Interest income decreased by approximately $0.2 million ³⁰, or 83% ³¹, to less than $0.1 million ³² in 2025 from $0.249 million ³³ in 2024, due to a decrease in cash and interest rates ³².

Significant operational developments during the period include a strategic shift in November 2025 to prioritize digital asset treasury management and investment in the Canton Network ¹. This shift was supported by a private placement offering in November 2025, which raised approximately $545 million ³⁴ in gross proceeds, including $99.4 million ³⁵ in cash and $446.2 million ³⁶ in cryptocurrency. The company also established an at-the-market (ATM) program and a shelf registration statement, and completed a registered direct offering in January 2026 for gross proceeds of approximately $54.9 million ³⁷. Management changes occurred in November and December 2025, with Mark Wendland appointed as CEO and Chairman, Mark Toomey as President, and Jacob Asbury as CFO ³⁸.

The company's outlook is heavily focused on its new digital asset treasury strategy, which centers on acquiring, holding, and deploying Canton Coin (CC) and supporting the Canton Network through validator operations, application support, and ecosystem participation ³. The strategy is designed to supplement the company's capital allocation framework by integrating a forward-looking, technology-driven approach to treasury management ².

A major growth area is the Canton Network itself, which is described as a public, permissionless blockchain with configurable privacy designed for institutional scale, connecting leading institutions for secure and interoperable transactions ². The company plans to operate as a Super Validator and run additional validator nodes on the Canton Network, expecting to earn recurring protocol-based validation rewards in CC and support network security, resiliency, and governance ². The company also intends to build, sponsor, or invest in applications and middleware that complement capital markets transactions on the Canton Network, focusing on projects that drive network utilization and expand institutional adoption, with the objective of increasing transaction activity and long-term network value ². Collaboration with other Super Validators and ecosystem participants, including financial institutions, technology providers, and application developers, is also a key part of the strategy to enhance the use case for Canton Network infrastructure and workflows ².

In terms of capital allocation, the company may access capital markets, including through its ATM program and other offerings, with the objective of deploying a portion of the net proceeds toward additional CC acquisitions and Canton-related ecosystem investments ². The company may also evaluate alternative financing structures designed to increase its CC exposure in a manner intended to be accretive to shareholders on a per-share basis ². Furthermore, a portion of CC holdings may be deployed into long-term locking programs to align with Canton governance frameworks and seek enhanced rewards, and the company may engage in CC lending and secured financing transactions to generate additional yield and improve capital efficiency ². The company may also utilize CC-linked options and other derivative income strategies, such as selling options or hedging structures, to manage risk and potentially enhance returns on its CC portfolio ².

The company explicitly notes structural headwinds and execution risks related to its strategic shift. The prioritization of the CC treasury strategy will require substantial allocation of executive time, attention, and resources, which will necessarily reduce the level of focus devoted to its biotechnology operations ³⁹. This shift in managerial focus could effectively result in the foregoing or delay of potential revenue streams and strategic opportunities that might otherwise be captured if management were fully dedicated to the biotech segment, adversely affecting operational performance and future revenue growth from biotechnology activities ³⁹. The company also remains exposed to potential liabilities from its prior business activities, including contractual obligations, intellectual property disputes, or customer claims, which could require significant financial resources and distract management ³⁹. Investor uncertainty and realignment are also flagged, as investors who initially invested for exposure to the legacy business may divest, potentially increasing stock price volatility and reducing market support during the transition ³⁹.

Canton Strategic Holdings, Inc. faces material risks stemming from its strategic shift to a digital asset treasury strategy. Macroeconomic risks include the extreme price volatility of Canton Coin (CC) and other digital assets, driven by market sentiment, macroeconomic conditions, regulatory developments, and technological vulnerabilities, which could result in substantial realized and unrealized gains or losses and significant volatility in reported earnings ⁴⁰. Regulatory risks are significant, as the laws and regulations applicable to digital assets are evolving and subject to interpretation and change, with potential for new laws or reclassification of CC as a security, which could impose registration, licensing, disclosure, custody, or capital obligations, or lead to the company's classification as an "investment company" under the 1940 Act if CC assets exceed 40% ⁴¹. Operational risks include dependence on third-party service providers for CC activities, where failures, outages, insolvencies, hacking, fraud, or operational errors could lead to partial or total loss of CC ⁴². Cybersecurity risks are paramount, as the loss, theft, or compromise of private keys, through cyberattack, insider malfeasance, software defects, or social engineering, may be irreversible and result in the loss of some or all CC tokens ⁴³. Liquidity risk exists as CC holdings are less liquid than cash and cash equivalents, and the company may be unable to sell CC at favorable prices during market instability ⁴⁴. Competitive risks arise from operating in an intensely competitive and rapidly evolving market for digital asset companies and investment vehicles, including other public companies with significant CC holdings and spot exchange-traded funds (ETPs) for digital assets, many of which may have greater financial resources and broader access to capital markets ⁴⁵. Furthermore, the availability of spot ETPs for CC and other digital assets may adversely affect the market price of the company's listed securities, as investors may choose ETPs for "pure play" exposure ⁴⁶.

Management's message to shareholders emphasizes a significant strategic pivot towards digital asset treasury management and investment in the Canton Network, marking a fundamental change from its historical biotechnology focus. The company believes this new strategy, centered on Canton Coin (CC), will drive value through activities on the Canton Network, which is seen as transforming global finance with configurable privacy and institutional adoption. Management intends to execute a diverse strategy including Validator Operations and Network Participation, Application Support and Strategic Investments, Collaboration and Ecosystem Advancement, Capital Raising and Treasury Expansion, and Token Management, all overseen by senior management and the Board with internal controls and risk limits in place. The company explicitly states that it expects to incur significant expenses and increasing operating losses for the foreseeable future ⁴⁷. However, due to recent fundraising activities, including net proceeds of over $537 million ⁴⁸ from a private placement offering in November 2025, management believes it has sufficient liquidity to fund anticipated cash requirements for operations and working capital purposes through at least March 2027 ⁴⁹.